United States Bioinformatics Market By Product & Services (Bioinformatics Tools, Bioinformatics Platforms, Bioinformatics Services), By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others), By Application (Metagenomics, Drug Discovery, Precision Medicine, Others), By End User (Institutional Research v/s Industrial Research), By Region, Competition Forecast & Opportunities, 2027

Abstract
United States bioinformatics market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing biotechnological procedures and techniques. Also, rising technical advancements like nucleic acid and protein sequencing, genetic engineering, and storage of the then-found data and its analysis further drive the growth of the United States bioinformatics market in the upcoming five years. Rising demands for biotechnological procedures for advancing medicine, finding the cure for diseases, etc. also supports the growth of the United States bioinformatics market in the next five years.
Application of the tools of computation and analysis to the collection and interpretation of biological data is termed bioinformatics. A conjugation of multiple fields like medicine, computer science, mathematics, and physics, forms bioinformatics. Moreover, the storage of the human genome project data and other similar genomic projects aids in the growing requirements of bioinformatics. The storage of the genome mapping data helps in analyzing underlying genomes and thus translated protein information of any new species. Microorganisms like bacteria, viruses, and fungi tend to mutate rapidly. The infectious diseases thus caused often lead to the urgency for devising treatments and vaccines against the microbes. The recent pandemic is one such example that actively utilized functions of bioinformatics in formulating the genome mapping of the coronavirus and its strain along with the vaccine and the pharmaceuticals.
Prevalence of Rare Diseases Promises Market Growth
Rapid outbreaks of new diseases and the growing prevalence of infectious diseases with unidentified strains of microorganisms, and their adversities drive the growth of the United States bioinformatics market in the upcoming five years. The definition of rare diseases in the country depends on the population it affects in a country or a region for a prolonged period. In the United States, if a disease affects less than 200,000 people it is categorized as a rare disease. In recent times, rare diseases along with infections have grown rapidly and affected a large population in the country.
The recent pandemic affected the worldwide population. In United States, over 81 million cases have been recorded in the country by March 2022 where 997,933 people died due to COVID-19. The United States was one of the few countries that came up with the vaccination and pharmaceuticals for viral infection, and the use of bioinformatics for the purpose was a boon. Therefore, the prevalent nature of such infectious diseases would support the growth of the United States bioinformatics market in the next five years.
Technological Advancement Guides Market Growth
Growing advancement in biotechnological procedures and processes drives market growth. Moreover, the evolution of big data technology is also fueling the technical advancement in the bioinformatics field. Using the technology for the analysis of the protein structure, functions, and further predictive analysis is substantiating the growth of the United States bioinformatics market in the future five years. Moreover, developments in systems biology and genomic analysis of pharmaceuticals have helped personalized medicine to transit from disease-centered and reductionism-based medical practice to system-based, integrative, and human-centered care.
Furthermore, increasing investment in research and advancement in bioinformatic systems & services is another major factor aiding the growth of the United States bioinformatics market. In the year 2021, USD 597.26 billion was spent on research and development in the healthcare sector. A large section was involved in pharmaceutical advancement and data storage regarding new protein translations, thus substantiating market growth in the country.
Market Segmentation
The United States bioinformatics market is segmented by product & services, type, application, end-user, competitional landscape, and regional distribution. Based on products & services, the market is further segmented into bioinformatics tools, bioinformatics platforms, and bioinformatics services. By type, the market is fragmented into genomics & proteomics, simulation studies & molecular modeling, genetic engineering, and others. Based on application, the market is bifurcated into metagenomics, drug discovery, precision medicine, and others. By end user, the market is differentiated between institutional research and industrial research. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among the South region, Mid-West region, North-East region, and West region.
Company Profile
Illumina, Inc., Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN Inc., 23AndMe, DataTrack International, Inc., Biovia-Dassault Systemes, Waters Corporation, SOPHiA GENETICS, among others is a partial list of major market players of the companies responsible for the growth of United States bioinformatics market.

Report Scope:
In this report, United States bioinformatics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
•United States Bioinformatics Market, By Product & Services:
oBioinformatics Tools
oBioinformatics Platforms
oBioinformatics Services
•United States Bioinformatics Market, By Type:
oGenomics & Proteomics
oSimulation Studies & Molecular Modelling
oGenetic Engineering
oOthers
•United States Bioinformatics Market, By Application:
oMetagenomics
oDrug Discovery
oPrecision Medicine
oOthers
•United States Bioinformatics Market, By End User:
oInstitutional Research
oIndustrial Research
•United States Bioinformatics Market, By Region:
oSouth Region
oMid-West Region
oNorth-East Region
oWest Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in United States bioinformatics market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).

Content
Table of Contents

1.Product Overview
2.Research Methodology
3.Impact of COVID-19 on United States Bioinformatics Market
4.Executive Summary
5.Voice of Customer
6.United States Bioinformatics Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.By Product & Services (Bioinformatics Tools, Bioinformatics Platforms, Bioinformatics Services)
6.2.2.By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others)
6.2.3.By Application (Metagenomics, Drug Discovery, Precision Medicine, Others)
6.2.4.By End User (Institutional Research v/s Industrial Research)
6.2.5.By Region
6.2.6.By Company (2021)
6.3.Product Market Map
7.United States Bioinformatics Tools Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Type
7.2.2.By Application
7.2.3.By End User
8.United States Bioinformatics Platforms Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Type
8.2.2.By Application
8.2.3.By End User
9.United States Bioinformatics Services Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Type
9.2.2.By Application
9.2.3.By End User
10.Market Dynamics
10.1.Drivers
10.2.Challenges
11.Market Trends & Developments
12.Policy & Regulatory Landscape
13.United States Economic Profile
14.Competitive Landscape
14.1.Competition Outlook
14.2.Company Profiles
14.2.1.Illumina, Inc.
14.2.2.Thermo Fischer Scientific, Inc.
14.2.3.Agilent Technologies, Inc.
14.2.4.PerkinElmer Inc.
14.2.5.QIAGEN Inc.
14.2.6.23AndMe
14.2.7.DataTrack International, Inc.
14.2.8.Biovia-Dassault Systemes
14.2.9.Waters Corporation
14.2.10.SOPHiA GENETICS
15.Strategic Recommendations